Nur für Handels- und medizinische FachmedienDie Patientenaufnahme für die Phase-III-Studie ReSPECT zur Prophylaxe von Pilzinfektionen bei Erwachsenen, die sich einer allogenen Blut- und Knochenmarktra ...

Somente para a mídia comercial e médicaInscrições finalizadas no estudo ReSPECT de Fase III sobre a profilaxia de infecções fúngicas em pacientes adultos submetidos a transplante alogênico de sangue e ...

The "Global Quantum Technology Market 2026-2046" report has been added to ResearchAndMarkets.com's offering.The global quantum technology market represents one of the most dynamic and strategically ...

Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into Jefferies Financial Group Inc. (NYSE: JEF) and Point Bonita Capital for potential violations of the federal ...

ProSpecBio, an evolving biotech company dedicated to providing highly purified proteins to the global research community, today announced the launch of its latest product: CHO cell–derived recombinant ...

Cognixion's non-invasive brain-computer interface powered by conversational AI, has been honored by TIME Magazine as one of the Best Inventions of 2025, celebrated for "giving voice to the voiceless." ...

Adults with Duchenne muscular dystrophy demonstrated functional improvements exceeding natural history, following 28-day treatment with SAT-3247Grip strength increased 118.6% and predicted forced ...

The "Saudi Arabia Essential Oils Market by Region, Competition, Forecast & Opportunities, 2020-2030F" report has been added to ResearchAndMarkets.com's offering.The Saudi Arabia Essential Oils Market ...

Solo para medios especializados en medicina y comercioFinalizada la inscripción en el estudio de fase III ReSPECT sobre la profilaxis de infecciones fúngicas en pacientes adultos sometidos a trasplant ...

Réservé aux médias spécialisés dans le commerce et la médecineFin du recrutement pour l'étude de phase III ReSPECT en prophylaxie des infections fongiques chez les adultes traités par transplantation ...

ME Therapeutics Holdings Inc. (“ME Therapeutics” or the “Company”) (CSE: METX) (FSE: Q9T), a publicly listed biotechnology company discovering and developing novel cancer fighting drugs in the field ...

Back-to-Back Developments Position Company for Significant Revenue Acceleration and Recurring Revenue Stream PLEASANTON, CA / ACCESS Newswire / October 10, 2025 / Healthcare Triangle, Inc.